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ABSTRACT 
The developing nervous system is particularly vulnerable to high level of glucocorticoids 
(GCs). Excess GCs is often associated with decreased birth weight in relation to gestational 
age, and to increased risk of psychiatric disorders, like depression, later in life. Persistent 
deregulation of the hypothalamic-pituitary-adrenal axis drive on central and peripheral 
systems has been suggested to play a central role, however the link between developmental 
GCs exposure and late-onset depression is poorly understood. The aim of this thesis was to 
investigate and characterize behavioral alterations induced by developmental exposure to 
excess GCs in mice. Twelve month old mice (C57Bl/6) exposed to dexamethasone (DEX) 
(0.05 mg/Kg/day s.c.) from gestational day 14 until delivery displayed depression-like 
behavior resistant to treatment with the SSRI antidepressant fluoxetine (FLX), and decreased 
neurogenesis. These alterations, not detected at younger age, were associated with 
deregulation of genes promoting progenitor stem cells quiescence and proliferation, such as 
Cdkn1c. Neuronal stem cells exposed to DEX in vitro exhibited changes in methylation of 
promoter regions of the same class of genes, suggesting the involvement of epigenetic 
mechanisms. Depression-like behavior is often associated with altered hippocampal 
connectivity of granule neurons in the dentate gyrus. We investigated the morphology of 
adult-born hippocampal granule neurons and found remodeling in dendritic arborization 
accompanied by changes in the expression of TrkB, DISC1 and Reelin. In addition, DEX-
exposed mice showed blunted circadian oscillations in corticosterone secretion, and down-
regulation of glucocorticoid receptor expression in the hippocampus, which may explain the 
resistance to FLX treatment. We then tested the SNRI antidepressant desipramine (DMI), 
which reversed the depressed phenotype. Since modifications in corticosterone fluctuations 
are also associated with circadian rhythm alterations, we tested whether DEX might alter 
circadian rhythms. Twelve month old DEX-exposed mice showed abnormal circadian 
entrainment, which appeared to be more rigid and strongly dependent on photic drive. 
Interestingly, circadian alterations were displayed already at 6 months, long before the onset 
of depression-like behavior, and were reduced by chronic DMI administration. We assessed 
the function of the central clock and its drive on the hippocampus. The expression of 
arginine-vasopressin, the main output of the suprachiasmatic nucleus (SCN), was 
downregulated in DEX-exposed mice, suggesting a decoupling of the SCN control on the 
hippocampus. The core clock gene Bmal1 showed robust circadian fluctuations in the DEX-
exposed mice SCN, while the oscillations were abolished in the hippocampus. The marked 
de-synchronization of Bmal1 across the SCN and hippocampus was restored by chronic 
treatment with DMI. Neither depression nor morphological and circadian alterations were 
developed in mice that received chronic treatment with DMI at 6 months, suggesting that the 
restoration of norepinephrine transmission might prevent the appearance of the phenotype. 
All together our results indicate that prenatal exposure to DEX triggers early changes in 
circadian rhythmicity, alterations in adult neurogenesis and neuronal plasticity preceding the 
onset of depression-like behavior.  
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1 INTRODUCTION 
1.1  BACKGROUND  
Homeostasis and adaptation to environmental challenges are achieved through complex 
molecular mechanisms and drive behavior towards the best strategy for survival. In utero 
developmental programming assists early adaptation and prepares the embryo to adequately 
respond to the post-natal environment. Any excessive and continuous disturbance at different 
levels, particularly during critical stages of embryonal maturation, may lead to early life 
programming alterations and long term metabolic anomalies and psychiatric disorders in 
adult life, which might even be passed onto the next generation (Gluckman and Hanson, 
2004). Over-exposure to glucocorticoids (GCs) has long been proposed as the most plausible 
link between adverse prenatal milieu and adult disorders (Reynolds, 2013). 
High levels of cortisol in humans affects the biochemical milieu of the fetus and correlate 
with a greater incidence of prematurity and low birth weight (Field et al., 2009, 2006; Maina 
et al., 2008). Insufficient gestational growth is associated with high risk for hypertension, 
cardiovascular diseases, obesity and metabolic disorders, such as diabetes, as well as delayed 
neurological development, ADHD and depression in adulthood (Grissom and Reyes, 2013; 
Longo et al., 2012; Pesonen et al., 2009; Ra and Ja, 2014; Räikkönen et al., 2008; Strang-
Karlsson et al., 2008). In pregnant women many factors contribute to increase the risk for GC 
over-exposure in the fetus: poor nutrition, stress and depression as well as maternal infection 
and inflammation, hypoxia and genetic deficiency of placental 11β-Hydroxysteroid 
Dehydrogenase (11βHSD2) all correlate with elevated cortisol which ultimately increase the 
risk for intrauterine growth retardation (IUGR) (Barker et al., 1993; Cottrell and Seckl, 2009; 
Martyn, 1994; Seckl, 2004).  
Since the publication of a landmark trial by Liggins and Howie in 1972 (Liggins and Howie, 
1972), synthetic GCs administration to pregnant women at risk of preterm delivery has 
become a standard procedure to significantly reduce infant mortality. The study showed that 
administration of synthetic GCs or glucocorticoid receptor (GR) agonists (such as 
dexamethasone (DEX) or betamethasone) in preterm labor could reduce the risk of infant 
respiratory distress syndrome. This led to a worldwide implementation of corticosteroid 
administration in cases of pregnancies with high risk of premature birth. Despite the synthetic 
corticosteroids’ short term beneficial effects, epidemiological studies have shown that the 
long-term effects include persistently altered hypothalamic –pituitary-adrenocortical (HPA) 
axis response to stress, and possible adverse health effects in adulthood (Waffarn and Davis, 
2012). Similarly, in animal models studies on synthetic GCs administration during pregnancy 
showed deregulation of the HPA axis accompanied by a GR gene expression decrease in the 
hippocampus (Levitt et al., 1996) altering the hippocampal drive on HPA axis activity 
(Sapolsky et al., 1984; Shoener et al., 2006), and resulting in HPA hypo-responsiveness 
(Sloboda et al., 2007). Prenatal exposure to excess GCs has been shown to also increase the 
susceptibility of neural cells to oxidative stress inducing modifications of the developmental 
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programming of the internal auditory system (Canlon et al., 2003) and altering the antioxidant 
levels and mitochondrial function in cerebellar granule cells (Ahlbom et al., 2000). 
1.2 GLUCOCORTICOIDS 
The end product of the HPA axis are the GCs, a class of steroid hormones that exert their 
effect through both mineralocorticoid receptors (MR) and GR. GCs reach their target cells 
and activate their intracellular receptors, which dimerize before binding to glucocorticoid or 
mineralocorticoid responsive elements in the nucleus to regulate (increasing or suppressing) 
transcription of specific genes. The biosynthesis and release of GCs is induced by the Adreno 
Corticotropic Hormone (ACTH) released in the blood from the anterior pituitary gland. 
ACTH release is triggered by the Corticotropin Releasing Hormone (CRH) produced by the 
parvocellular neurons in the paraventricular nucleus (PVN), transported to the external zone 
of the median eminence and then reaching the anterior pituitary through the portal vascular 
system. Circulating GCs mediate the stress response and provide negative feedback to the 
pituitary gland to inhibit ACTH release, as well as to the PVN to inhibit CRH release. As part 
of the regulatory feedback loop, hippocampal neurons, expressing receptors for GCs, send 
inhibitory input to suppress the hypothalamic release of CRH (Mastorakos and Ilias, 2003). 
Therefore, the hippocampus is both a target and a regulator of the brain’s response to stress. 
Endogenous levels of GCs are tightly regulated not only by the HPA axis activity, but also 
depend on the activity of intracellular 11β-HSD enzymes, which convert active GCs into their 
inactive 11-keto metabolites (Sheppard, 2003).  
During organogenesis, GCs induce cell proliferation, differentiation and maturation of several 
organs including kidney, cardiovascular system and gastrointestinal tract. Most importantly 
GCs promote lung maturation and surfactant production, which are essential for postnatal 
survival (Harris and Seckl, 2011; Khulan and Drake, 2012; Ward, 1984). GCs also promote 
brain development by initiating terminal maturation, remodeling of axons and dendrites, and 
affecting cell survival (Cameron and Gould, 1994; Meyer, 1983; Yehuda et al., 1989). Most 
notable is their role in the development and function of the limbic system and regulation of 
the HPA axis activity as early as 18 gestational weeks in humans. 
GCs effects on developmental programming depend mostly on the time-frame of the 
exposure and can persist not only in adult life but can be passed onto the offspring, 
suggesting the involvement of epigenetic modifications (Drake et al., 2011, 2005). Indeed, 
alterations in gene expression consequent to stress exposure correlates with increased HPA 
axis responsivity, changes in CRH and GR expression associated with alterations in promoter 
methylation in animal models (Mueller and Bale, 2008).  
1.3 NEUROGENIC THEORY OF DEPRESSION AND GLUCOCORTICOIDS IN 
THE HIPPOCAMPUS 
The hippocampus is a highly plastic region of the mammal’s brain that preserves neurogenic 
activity in adulthood and is integral to the regulation of stress responses (Anacker et al., 2013; 
McEwen, 2002). GC-sensitive hippocampal neurons are involved in terminating the 
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adrenocortical stress response (Sapolsky et al., 1984) but their beneficial effect on stress 
adaptation is compromised by excessive and prolonged exposure. Sub-chronic exposure to 
DEX inhibits adult hippocampal neurogenesis in rats (Kim et al., 2004) and promotes 
oligodendrogenesis (Chetty et al., 2014). The hippocampus is also vulnerable to 
developmental insults: administration of synthetic GCs in mice at post-natal day (PND) 6, 
affects the precursor neural stem cells niche size through adulthood (Kim et al., 2004; Ortega-
Martínez and Trejo, 2014). 
In addition, exposure to high levels of corticosterone affects the electrophysiological 
properties of immature neurons by reducing their activation in the ventral hippocampus in 
response to spatial and non-spatial memory tasks (Workman et al., 2015). de Kloet and 
colleagues reviewed a differential mechanism through which GCs directly affect 
hypothalamic and hippocampal regions: MR binding exerts a rapid effect on glutamatergic 
neurons while GR binding mediates a slower genomic response to stressors (de Kloet et al., 
2008).  
The differential binding to MR or GR has been proposed as a possible mechanism through 
which GCs regulates early and adult neurogenesis. MR activation increases hippocampal 
progenitor cell proliferation and promotes astrocytic differentiation; GR activation decreases 
proliferation and promotes neuronal differentiation, counteracting the MR-induced increase 
in astrogliogenesis. The proposed molecular mechanism is that GCs decrease neuronal 
differentiation by Notch/Hes signaling, FOXO3A signaling, TGFb-SMAD2/3-signaling and 
Hedgehog signaling (Anacker et al., 2013). In addition, GCs were reported to decrease 
proliferation of embryonic neural stem cells through Ubiquitin-mediated degradation of 
cyclin D1 in vitro (Sundberg et al., 2006), and Caveolin-1 seems to mediate the anti-
proliferative effect of GCs (Peffer et al., 2014). 
Developmental exposure to excess GCs has been associated with higher risk for late-onset 
psychiatric disorders, and with depression in particular (Harris and Seckl, 2011; Räikkönen et 
al., 2008). According to the monoamine hypothesis, depression is the result of serotonin (5-
HT), norepinephrine (NE), and dopamine (DA) neurotransmission imbalance in specific 
brain regions (Hamon and Blier, 2013). The neurogenic theory of depressive disorders 
emphasizes the link between hippocampal neurogenesis and depression: decreased 
neurogenesis following chronic stress can reduce the inhibitory activity of the hippocampus 
on the HPA axis (feedback loop). The suggested consequences are HPA axis hyperactivity, 
increased blood levels of stress hormones, and hippocampal damage, all common features of 
major depressive disorders (MDD). Nevertheless, the relationship between structural 
hippocampal changes and depression is still unclear (Dranovsky and Hen, 2006). The 
monoamine hypothesis and neurogenic theories of depression converge in that 5-HT 
depletion inhibits adult neurogenesis (Brezun and Daszuta, 1999), while chronic, but not 
acute antidepressant treatment promotes neurogenesis in the sub granular zone (SGZ) of 
dentate gyrus (DG) (Duman et al., 2001; Malberg et al., 2000; Wang et al., 2008). In addition 
GCs regulates the progenitor cells sensitivity to 5-HT receptor activation in the DG (Huang 
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and Herbert, 2005) while the HPA axis can influence the sensitivity of the 5-HT system by 
affecting the binding of 5-HT to its transporter (Figlewicz, 1999). The majority of known 
antidepressants, such as serotonin and/or noradrenaline reuptake inhibitors, serotonin 5-HT1A 
receptor agonists, and the melatonin receptor agonist / serotonin 5-HT2B/C receptor antagonist 
agomelatine, increase proliferation and maturation and survival of newborn hippocampal 
cells in rodents (Duman et al., 2001, 1999; Malberg and Duman, 2003; Wang et al., 2008). 
The effect of 5-HT on neuron proliferation depends on the recruitment of different types of 5-
HT receptors (Banasr et al., 2004; Jacobs et al., 2000; Santarelli et al., 2003) with a 
preferential involvement of 5-HT1A receptors. A 3-week treatment with the SSRI fluoxetine 
(FLX) in rodents increases cell proliferation in the DG by 70% (Duman et al., 2001), but this 
effect is not present in 5-HT1A receptor knock- out mice (Santarelli et al., 2003) or in animal 
models with ablation of hippocampal neurogenic niche by irradiation (Czéh et al., 2001; 
Santarelli et al., 2003).Therefore it has been proposed that the antidepressant effects may be 
mediated by hippocampal cell proliferation counteracting the reduced neurogenesis observed 
in animal models of depression and possibly in human patients with MDD (Masi and 
Brovedani, 2011). 
1.3.1 Granule cells morphology in the adult hippocampus: implication for 
depression 
The mood-improving action of antidepressants do not solely depend on neurogenesis 
restoration but it is also associated with neuronal remodeling (Bessa et al., 2009; David et al., 
2009; Miyamoto et al., 2011; Seo et al., 2014) through monoamine direct actions (Rojas et 
al., 2014; Yan et al., 1997), and up-regulation of genes involved in neuronal proliferation, 
differentiation, and plasticity (Förster et al., 2006; Llorens-Martín et al., 2016). FLX and 
desipramine (DMI), for instance, have been reported to restore not only neurogenesis (Chen 
et al., 2006; Guirado et al., 2012), but also the complexity of dendritic arborization and the 
density of dendritic spines in the hippocampus (Laifenfeld et al., 2002; Norrholm and 
Ouimet, 2000). Changes in hippocampal function and in the morphology of hippocampal 
neurons have been described in depressed patients as well as in animal models of depression 
(Campbell and MacQueen, 2004; Kulkarni and Firestein, 2012; Magariños et al., 1996; Miller 
and Jacobs, 1984; Watanabe et al., 1992).  
The morphology of granule neurons plays a key role in the physiological function of the 
hippocampus: dendrites from the hippocampal granule cells spread throughout the inner and 
outer molecular layer, where commissural associational fibers (CAF) from contralateral or 
ipsilateral granule cells and entorhinal cortex (EC) projection, respectively, establish synaptic 
connections. The reduction in dendritic complexity and synaptic spine density in the 
molecular layer may reflect a disconnection of the EC inputs to the hippocampus with 
consequent impairment of hippocampal function (Llorens-Martín et al., 2016). 
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1.3.2 Disruption of circadian rhythms and neuropsychiatric disorders 
The circadian clock is an internal oscillator identified in all living organisms, which allows 
the synchronization of biological function to the light-dark cycle (Ko and Takahashi, 2006). 
In mammals, including humans, this function is performed by a population of neurons located 
in the SCN. The SCN consists of several neuronal populations that display prominent cyclic 
fluctuations in firing patterns. The activity of SCN networks synchronizes the circadian 
fluctuations in physiological functions, including hormonal and autonomic regulation of 
metabolism with the dark-light cycle (see (Albrecht and Oster, 2001; Kiessling et al., 2010; 
Leliavski et al., 2014) (Fig. 1-1). The most important signal that is able to reset the circadian 
clock and synchronize it with an externally imposed rhythm is light. Thus, in addition to 
merely keeping the pace for spontaneous activity, the SCN function also has a degree of 
plasticity/adaptability. The regular distribution of activity and resting/sleep periods is an 
example of output of the circadian clock (Hu et al., 2009).  
Arginine-vasopressin (AVP) is the main output from SCN (Kalsbeek et al., 2010) and plays a 
critical role in driving slave oscillators (e.g. hippocampus) through HPA axis rhythmic 
activity (Buijs et al., 1999). Within the SCN, AVP signaling is critical for the synchronization 
of neuronal firing patterns, and decreased AVP signaling in the SCN renders the self-
sustained oscillation more sensitive to re-entrainment (Yamaguchi et al., 2013). The SCN 
expresses alpha-adrenoceptors (Morien et al., 1999) and receives noradrenergic innervation 
from locus coeruleus (LC) (Cagampang et al., 1994). Although the role of NE in regulating 
the SCN is not clear it has been proposed that NE modulates the expression of AVP in SCN 
in a circadian fashion and may account for the mechanism of action of medications (e.g. 
SNRI) for the treatment of psychiatric disorders often associated with circadian asynchrony 
(O’Keeffe et al., 2012; Someren, 2010; Wirz-justice, 2009). The relationship between 
circadian rhythm disruption as the result of variation in environmental cues (light/dark ratio 
and light pollution) and occurrence of depression has been reviewed by Salgado-Delgado and 
colleagues (Salgado-Delgado et al., 2011). The author suggests that the lack of synchronicity 
between internal rhythmicity in GCs and neurotransmitters concentration, and exposure to 
Figure 1-1 Schematic representation of the timing 
system. The central clock, located in the SCN, is 
entrained by environmental light via the retino-
hypothalamic tract. It controls the activity of the 
HPA axis via AVP release to the PVN. Circulating 
GCs entrain peripheral oscillators (e.g. skin 
fibroblasts) as well as slave oscillators located in 
the brain. The hippocampus contributes to the 
feedback loop by inhibiting the release of CRH 
from the PVN. 
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time indicators such as light, feeding schedules and physical activity play a key role in 
etiopathogenesis of depression (Salgado-Delgado et al., 2011). Similarly, changes in 
molecular rhythms in SCN and in Nucleus Accumbens (NA) have been reported subsequent 
to induction of depression in animal models (Logan et al., 2015). The connection between 
circadian rhythms and MDD is supported by the following lines of evidence: 
1) mutations in clock genes are associated with depression (MDD, seasonal affective 
disorder (SAD), as well as sporadic depressive episodes) (Albrecht, 2013; Lavebratt et 
al., 2010; Partonen et al., 2007)  
2) interfering with normal circadian rhythms (e.g., shiftwork) increases the risk of 
developing MDD or precipitates the recurrence of MDD episodes (Scott et al., 1997)  
3) SAD occurs during winter, and is triggered by short light phase during winter months. In 
animal models, exposure to either continuous darkness or continuous light for extended 
periods of time leads to depression-like behavior (Tapia-Osorio et al., 2013) 
4) therapeutic approaches aimed at restoring/resetting/regulating the circadian rhythms are 
most often effective in controlling mood. Moreover, treatment with melatonin (a 
hormone secreted by the pineal gland only during the dark phase, and controlled by 
direct input from the retina), or agomelatine (a melatonin receptor agonist with 
established antidepressant effects) are effective mood stabilizers (Mairesse et al., 2013; 
Marrocco et al., 2014)  
The analysis of single genes variants in animal models of depression and in postmortem 
human samples with clinical history of MDD has so far provided information about very 
specific and restricted landmarks of circadian rhythm alterations and concomitant depression: 
variants of single clock genes in animal models has proven to correlate with abnormal sleep 
behavior but the normal rhythm appears to be disrupted only in response to variation in 
environmental cues suggesting that a broader family of gene contributes to specific 
phenotypes (Jones et al., 2013). Genome-wide association studies for sleeping disorders have 
so far shown a non-significant correlation between clock genes variants and sleeping 
disorders indicating that a functional genomic (transcriptomics) approach might prove to be 
more reliable. In fact it was shown that circadian patterns in the transcriptome of healthy 
donors are in-phase across six regions analyzed: SCN, dorsolateral prefrontal cortex, anterior 
cingulate cortex, hippocampus, amygdala, NA, and cerebellum. The patterns involve several 
hundred transcripts, led by the best-known clock genes such as BMAL1. Authors report that 
gene expression rhythms are intrinsically stable and inert to sudden changes in environmental 
cues outside of the SCN (Li, 2014). 
At a subcellular level, the core of the molecular clock consists of a network of transcription 
factors, referred to as the clock genes, engaged in interlocking feedback loops (Ko and 
Takahashi, 2006). The cyclic function of the clock maintains a large degree of adaptability by 
integrating information on metabolic status and level of activity with environmental cues (e.g. 
ambient light intensity) in order to stabilize the 24 h periodicity. Interestingly, in the SCN and 
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hippocampus, alterations in synchronous neural activation due to variation in light exposure 
change the DNA methylation patterns (Azzi et al., 2014; Molyneux et al., 2008). 
1.3.3 Glucocorticoids and circadian rhythms 
GCs in adults regulate daily events and coordinate sleep activity by their intermittent 
secretion from the adrenal glands through the HPA axis activity, but can readily rise in 
response to stress. At a basal level, GCs follow ultradian and circadian rhythms with peaks 
occurring before the onset of the active phase in mammals (de Kloet et al., 2008). The 
ultradian and circadian modulation of GCs secretion is finely tuned by differential binding to 
MR or GR in target cells controlling basal homeostatic functions. In addition, the response of 
the adrenal cortex to ACTH signaling is gated by an intrinsic mechanism that depends on 
cyclic expression of clock genes.  
At cellular level, the timing of GCs action is determined by GRs availability and heat shock 
protein (HSP) regulation: GCs bind to GR-HSP complexes and then translocate to the 
nucleus and interact with glucocorticoid response elements (GREs) on their target genes. The 
cycle is completed when GRs lose their ligand in the nucleus and are recycled through 
nuclear HSPs in the cytoplasm, ready for new binding to HSP and GCs. Interestingly the GR-
GRE binding and release cycles is subordinated to HSP-mediated cycle (de Kloet et al., 2008; 
Dickmeis et al., 2013). It should be noted that these events occurring in a time-scale of 
minutes are superimposed onto a family of genes with intrinsic cyclic activity like clock 
genes: the CLOCK/BMAL1 target gene Per1 contains a GRE element in its promoter that is 
rhythmically bound and regulated by GCs in ultradian pulses both in cultured cells and in the 
hippocampus (Conway-Campbell et al., 2010; Stavreva et al., 2009). Moreover CLOCK 
regulates in a negative-feedback loop the GCs activity inhibiting the GR by acetylation and 
CRY activation (Lamia et al., 2011; Nader et al., 2009). Thus, it is proposed that there is 
cross-talk between the circadian clock gene machinery and GR signaling at both the 
transcriptional-regulation level, and the direct protein interaction level.  
Clock genes are responsible for a transcriptional and translational auto-regulatory loop of 
molecular oscillation not only in the SCN, but also in peripheral tissues (Ko and Takahashi, 
2006). They are expressed also in adult neuronal stem cells and are correlated with adult 
neurogenesis (Matsumoto et al., 2011) in relation to dark/light cycles (Guzman-Marin et al., 
2007). Studies on neurosphere derived from murine neural stem/progenitor cells have 
revealed that Clock and Bmal1 are required for neurosphere formation, proliferation and cell 
survival. Furthermore, neurospheres display circadian rhythm in mPer1 expression, which 
regulates neurogenic transcription factors such as NeuroD1 (Kimiwada et al., 2009). 
Commitment to a neuronal fate is dependent on Bmal1 expression (Malik et al., 2015). 
Bouchard-Cannon and colleagues have shown that the molecular clock controls cell 
proliferation through Bmal1 and Per1 regulation of the cell cycle entry and exit and by mean 
of a cyclin dependent kinase inhibition (Bouchard-Cannon et al., 2013). More recently 
Watanabe and colleagues have proposed a specific mechanism for regulation of the timing of 
neuronal differentiation through an Hbp1 mediated control of cell cycle progression during 
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cortical development (Watanabe et al., 2015). Interestingly, in an in vivo analysis of adult 
progenitor cell differentiation, circadian variations seem to correlate more often with 
gliogenesis rather than with neurogenesis (Kochman et al., 2006). These observations 
underline the important influence of the clock genes on neurogenesis regulation. 
In the vast spectrum of symptoms of MDD and Bipolar Disorders (BD), sleep disturbance 
and diurnal mood variation are among the most common (Hall et al., 1964; Riemann et al., 
2002), suggesting the possibility of clock dysfunction in relation to GCs fluctuations.  
Despite the abundant knowledge achieved during the last few decades on the field, the 
specific mechanisms through which developmental GCs exert their long lasting pleiotropic 
effects in mammals remain unclear. The impact of GCs on hippocampal neurogenesis and 
neuronal morphology, in relation to depression-like behavior, and circadian alterations 
require further investigation. The evaluation of appropriate pharmcological approaches to the 
complex and long-lasting pathologic condition resulting from GCs in utero exposure needs to 
take in account possible mechanisms not yet considered as plausible candidates. 
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2 AIMS 
The general aim of this thesis was to explore the impact of deranged prenatal hormonal 
milieu induced by excess GCs in mice. 
The specific objectives of the study were: 
A. To investigate the effect of prenatal DEX exposure in relation to late onset depression-
like behavior and possible causal link with other behavioral changes, namely circadian 
rhythm alterations; 
B. To assess the impact of DEX on hippocampal neurogenesis and maturation of adult-
born neurons in relation to behavioral alterations;  
C. To evaluate different classes of antidepressants and their possible regulatory 
mechanism on neurotransmission, neurogenesis, and neuronal morphology.  
D. To explore possible molecular mechanisms underpinning the phenotypical alterations 
consequent to developmental exposure to DEX. 
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3 MATERIAL AND METHODS  
The purpose of the following section is to offer an overview on the experimental design and 
methodological consideration that arose in the planning and realization of the projects 
composing the thesis. The reader will find detailed description of each experimental 
procedure in each constituting paper. 
3.1 ANIMALS AND EXPOSURE 
All experiments were performed in agreement with the European and Swedish national 
regulation following approval by the local Animal Ethics Committee (Stockholms Norra 
djurförsöksetiska nämnd).  
The exogenous administration of GC during early developmental stages leads to lower 
birth-weight, and in utero growth restriction/retardation (IUGR). There is increasing 
evidence that IUGR increases the risk of psychiatric disorders later in life (Anacker, 2014; 
Räikkönen et al., 2008; Strang-Karlsson et al., 2008). An adverse perinatal environment 
appears to have detrimental effects not only on HPA axis regulation, but also on the 
programming of the SCN, ensuing alterations in circadian rhythms often associated with 
depression in humans (reviewed in (Kennaway, 2002)). GCs-induced IUGR models are 
highly relevant, since GCs administration to women threatened by premature labor is 
widely used in clinical practice as commented in the introduction (Haugaard and Bauer, 
2001). IUGR provides a model for metabolic stress that leads to acquired allostatic load as a 
chronic state imbalance in response to stress (maladaptation), and it is strongly related to 
behavioral alterations later in life (Anacker, 2014).  
In this thesis we used a model of GCs developmental exposure in C57Bl/6 mice which 
leads to fetal growth retardation, and postnatally to lower bodyweight until the age of 4 
weeks. The choice of mice versus rats was originally made in the perspective of the 
possible implementation of transgenic animals, mostly common in mice. We chose 
C57BL/6J mice because no particularly high emotionality is described for this strain and 
behavioral alteration should be displayed solely as the result of prenatal DEX exposure. 
Timed-pregnant dams (Charles River, Germany) were injected subcutaneously with 0.05 
mg/k/day DEX (Sigma-Aldrich, Sweden) dissolved in sterile saline or equivalent volume of 
vehicle (10 mL/kg b.w. physiological saline) from gestational day (GD) 14 (the day the 
postcoital plug was considered GD 0) until delivery (recorded as PND 0). This dose was 
chosen to induce a moderate fetal growth retardation without affecting litter size, 
gestational length or maternal behavior (as assessed by pup retrieval test described 
below)(Celsi et al., 1998). A preliminary battery of behavioral tests showed alterations only 
in DEX-exposed males therefore we used only male offspring for subsequent studies.  
The procedure for offspring handling is described in details in each paper.  
The litters were culled to 4 pups per litter at PND 3 and the weight was monitored at PND 
3, 7, 14 and 21. At PND 21 the mice were weaned in groups of 4-5 mice per cage and 
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tagged with subcutaneous radio frequency identification (RFID) transponders under brief 
isoflurane anesthesia for unambiguous identification of the pups throughout the 
experiments. The transponders were also used for monitoring the animal activity in their 
homecage environment. After implantation, the pups were redistributed to new cages so 
that each cage would house a maximum of five mice originating from different litters and 
the distribution was maintained throughout the study. Mice were kept in an animal facility 
under 12:12-h light–dark (LD) cycle (light intensity 50 lx; light on at 0600 hours) at 
constant temperature (22±1 °C) and humidity (50±5%). 
3.2 BEHAVIORAL TESTS 
The choice of behavioral test in the emotional domain was intended to minimize the 
exposure to stressful events related to unnecessary handling. The number of animals for the 
planned tests were decided based on the test with known higher variance (higher number 
required), and on meta-analysis on our strain, in order to establish a good compromise 
between a reasonable number of animals, high power and ethical considerations for animal 
use. In a preliminary set of experiments FST revealed an 80% power with 8 animals per 
group given the fairly low variance in our model. The assessment of spontaneous activity in 
the homecage using the TraffiCage™ system is particularly relevant for our approach and 
provides a valuable tool for unmasking specific anomalies related to prenatal DEX 
exposure.  
3.2.1 Pup retrieval test 
Since prenatal DEX exposure is achieved by DEX s.c. injection in E14 pregnant dams, and 
to rule out any possible confounding independent variables such as maternal behavior as 
effect of DEX treatment, we evaluated maternal care by means of a pup retrieval test. The 
test was adapted from (Umemura et al., 2015): briefly, pups at PND 3 were separated from 
their mothers for 10 min and only four male pups were returned in the respective mother’s 
homecage, and placed at the more distant corners from the nest. The behavior was recorded 
for 10min using a video camera and analyzed offline by one investigator who was blind to 
the treatment conditions. Before the beginning of the recording session the quality of nest 
building was assessed by scoring from 1 to 4 (1 corresponded to disorganized nest structure 
or inconsistent use of nesting material; 4 to regular nest building and constant care of nest 
consistency). Three maternal behaviors were measured during the video analysis: the 
latency to first retrieval; time for each pup retrieval to the nest; the total time spent in the 
nest for maternal care; the time spent apart from the nest which was considered as 
neglecting behavior.  
3.2.2 Forced Swim Test (FST) 
The assessment of depression-like behavior was conducted with the FST at different ages 
and before and after each antidepressant treatment. Also known as Porsolt’s test (named 
after the scientist who first proposed it in 1977) the FST is based on the principle that an 
animal exposed to an aversive stimulus will attempt to escape until it will stop and become 
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immobile. The duration of immobility is used to score depression-like behavior. The 
animals are individually placed for 6 min in glass cylinders filled with water (23°C), and 
test sessions are videotaped and analyzed offline. We considered immobility as passive 
floating for at least 2 seconds. In virtue of its high predictivity, reliability and 
reproducibility, FST is probably the most frequently use paradigm for the measurement of 
depression-like behavior and for testing antidepressants in rodents. The different behaviors 
displayed in response to aversive stimuli (swimming, climbing, struggling, and floating) 
have been proven to be associated with specific neurotransmitter activity, and hence 
predictive for various classes of antidepressant responsiveness (Cryan and Mombereau, 
2004). Other paradigms for assessment of depression are known to either produce similar 
results (e.g. tail suspension test) or require shock presentation or long-term manipulation 
and training (e.g. learned helplessness, novelty-induced hypophagia test). We have 
confirmed the depression-like behavior in our model by tail suspension test. In later 
replicates, we observed a very consistent pattern of alterations and did not use the tail 
suspension test in order to minimize the animal stress and discomfort. 
3.2.3 Spontaneous Activity 
The monitoring of spontaneous activity is a non-invasive powerful tool to unmask behavioral 
alterations related to pathological conditions and more subtle mood disorders (Dawkins, 
2006; Weary et al., 2014). The analysis of spontaneous behavior, which takes advantage of 
a more ethologically valid environment (Peters et al., 2015), has a prominent role in this 
thesis especially in relation to the effects of changes in light/dark conditions. Rodents are 
nocturnal mammals and display most of the exploratory activity during the dark phase in 
24-h cycles with high degree of adaptability to changing in light-dark conditions. 
Continuous monitoring in a social and stimulating homecage environment with a minimal 
(although inevitable) interaction with the experimenter, can: (1) provide important 
information about undisturbed animals’ activity level and distribution during active (dark) 
and inactive (light) phases; (2) reduce the introduction of confounding factors. We recorded 
the spontaneous activity of group-housed, freely moving mice using the TraffiCage™ 
system (NewBehavior, Zürich, Switzerland) which consists of an array of antennas 
embedded in a plate positioned under the homecage. The antennas can read the unique 
identification numbers stored in transponders implanted subcutaneously (RFID) and 
provide an approximate location of each animal with a time resolution of 20 ms. The 
system is able to detect the movement of each animal from one region of the cage covered 
by one antenna to a region covered by a different antenna and estimate the time spent in 
each region. A 'visit' is defined as the time interval during which an animal is detected 
constantly by the same antenna, and is used as activity count. The time series of visits are 
exported as ASCII files and analyzed using custom algorithm implementations in Matlab™ 
(The MathWorks, Natick, MA, USA). To minimize the confounding effects of novelty, we 
derived the baseline measurements based on three LD cycles after an acclimation period of 
at least three LD cycles. The circadian zeitgeber (German, 'time giver') time (ZT) 0 
corresponds by convention to the onset of the light phase.  
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For the analysis of the active phase in relation to the LD cycle the time series of visits were 
binned in 5 min non-overlapping epochs, then smoothed with a weighted average using a 
sliding Gauss window (2 h width). The epochs with activity above the individual’s 
detrended average were considered “active epochs”. The active phase was defined as a 
sequence of active epochs either contiguous or separated by gaps no larger than 1h. The 
onset and the offset of the active phase were defined as the ZT corresponding to the 
beginning and the end of the active phase, respectively. The duration of the active phase 
was calculated as the time span between the onset and the offset of the active phase during 
one LD cycle. For steady entrainment conditions, the analysis of active phase is based on 
three consecutive LD cycles. We considered spontaneous activity as entrained to the light-
dark cycle if the onset of the active phase occurred within 1 h from the onset of the dark 
phase. The individual delay in re-entrainment was estimated as the first day spontaneous 
activity was entrained to the shifted light-dark cycle.  
To analyze the synchronization of spontaneous activity with the light-dark cycle, we recorded 
spontaneous activity in several conditions. A period of two weeks in constant darkness (DD; 
free- running period) was used to measure the spontaneous activity in free-running 
conditions, while the ability to re-entrain to normal conditions was tested by resuming the 
LD cycle. We also challenged the mice to re-entrain to the LD cycle by abruptly shifting 
the light offset. This paradigm is particularly suited to address the complex interactions 
between the internal clock and peripheral oscillators, because it allows the dissection of 
behavior features either SCN-specific, or pertaining to entrainment of activity as peripheral 
oscillator (i.e. independent from SCN).  
The analysis of circadian rhythmicity consisted of rhythmometry by means of cosinor 
analysis (Nelson et al., 1979; Refinetti et al., 2007). The period of spontaneous activity was 
estimated as the highest peak in the χ2-periodogram (Sokolove and Bushell, 1978) between 
20 and 25 h, with a 5-min resolution.  
We analyzed the variability of spontaneous activity by estimating the intra-daily variability 
(IV), and by means of detrended fluctuation analysis (DFA). Both methods describe the 
patterns of fluctuations in spontaneous activity without making assumptions about the 
periodic nature of the fluctuations, or about the shape of the cyclic fluctuations (e.g. 
sinusoidal or square waves). IV describes the instantaneous variability in activity, while 
fractal analysis describes the complexity of series of fluctuations over time.  
IV characterizes the patterns of activity within a 24 h cycle from the point of view of 
variations between consecutive time-bins. It was calculated as the ratio between the average 
squared differences between consecutive time-bins (pooled activity over 5 min in our case) 
and the global variance over the entire day (Gonçalves et al., 2015, 2014). It typically has 
values between 0 and 2; low values indicate smooth fluctuations between active and 
inactive episodes, while high values indicate fragmented activity patterns (Gonçalves et al., 
2015, 2014). 
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Fractal analysis had been proposed as an analytical tool to distinguish between animals 
operating in normal versus pathological states (see (Macintosh et al., 2011)). DFA measures 
long term autocorrelation in data derived from sequential patterns of activity. The method is 
based on linear regression analysis of the residual variance of the time series against the 
timescale used for detrending on double-logarithmic plots. The intervals for detrending 
ranged from 20 min to 21.3 h in exponential increments. The correlation coefficient of a 
linear regression in double-logarithmic plot translates into a scaling exponent, and describes 
the long-term autocorrelation patterns embedded in the time series (Peng et al., 1995). 
Scaling exponent of 0.5 represents a non-correlated, random sequence (white noise), while 
scaling exponent ≠ 0.5 indicates that the sequence displays long-range autocorrelation, i.e. 
the durations of a bout of activity depend on the duration of other bouts. If the scaling 
exponent has a value < 0.5 long bouts are more likely to be followed by short bouts and 
vice versa. If the scaling exponent is > 0.5, the sequence is persistent, long bouts are more 
likely to be followed by long bouts. The scaling exponent in young, healthy rodents and 
humans is around 0.8 (Hu et al., 2012, 2007). Values approaching 1 can be interpreted as 
reductions in complexity with strong underlying regularity (Peng et al., 1995), and are a 
hallmark of disease (Macintosh et al., 2011).  
3.2.4 Analysis of synchronization of peripheral oscillators with the SCN  
The central clock located in the SCN synchronizes all biological processes and behaviors to 
match peripheral oscillators with the LD cycle. While the main purpose is to maintain the 
overall synchronization, the SCN function must also have a degree of plasticity to allow the 
organism to adapt to changes. An abrupt change in the LD cycle induces a transient 
desynchronization of all oscillators with complex, but reversible biological disturbances as 
observed in the jet-lag syndrome. Therefore the integrity of SCN functions and its control on 
peripheral oscillators guarantees the ability to re-entrain at appropriate time. Mice were killed 
at the beginning of the subjective night (active phase) at different time points (N=2 / time 
point /group) every 1.5 h by an overdose of anesthetic (sodium pentobarbital, 150 mg kg
-1
), 
and tissue samples from the ear were harvested before perfusing transcardially with ice-
cold buffered saline followed by 4% paraformaldehyde. Brains were immediately dissected 
and RNA was extracted from different regions as described in the dedicated section.  
The mRNA expression of Bmal1 was first normalized to have 0 average and unit variance 
relative to the group and brain region (standard deviation scores). The state portraits were 
obtained by plotting the relative Bmal1 expression for each animal in the SCN and the 
hippocampus on x and y axes, respectively (one animal – one datapoint, connected by a line 
to illustrate the sequence of times of death). Since the diurnal fluctuations in Bmal1 
expression can be approximated by a sinusoidal curve, and the sinusoids for any two brain 
regions are in a constant phase relationship, the resulting plot should be a segment of 
ellipse. We approached the analysis of the state portraits as Lissajous figures, where the 
phase difference between the two sinusoids determines the orientation of the axis of the 
ellipse, and the direction of progression (Fig. 3-1). Thus, the state portraits provide an 
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illustration of the phase relationship, or lack thereof, between the two brain regions 
analyzed.  
3.2.5 Analysis of Bmal1 expression in skin fibroblasts 
Skin fibroblasts express functional molecular clock machinery (Nagoshi et al., 2004; Welsh 
et al., 2004), and the circadian oscillations in clock gene expression maintain to a large extent 
the features of circadian rhythms in the central clock (Brown et al., 2008; Pagani et al., 2010). 
The molecular clock machinery in the fibroblasts acts as a peripheral oscillator and is subject 
to entrainment by the central oscillator (located in the SCN) (Brown et al., 2008), similar to 
spontaneous activity (Yamazaki et al., 2000). The possibility to synchronize self-sustained 
oscillations, and to reset the phase is preserved in cultured fibroblasts (Bamne et al., 2013; 
Welsh et al., 2004). We investigated the expression of clock genes in fibroblast isolated from 
all groups at the age of 6 mo. Skin fibroblasts cultures from the tissue samples were 
prepared as described in detail in Paper I. After synchronization (by exposing the fibroblasts 
to 1μM DEX), the cells were harvested at different time points, mRNA was extracted and 
the relative expression of Bmal1 was assessed by quantitative PCR with Gapdh as the 
housekeeping gene (see also Supplementary Materials in Paper I). The oscillations in Bmal1 
mRNA expression were analyzed by cosinor rhythmometry (Nelson et al., 1979; Refinetti et 
al., 2007). 
3.3 CORTICOSTERONE METABOLITES IN FECES 
We investigated the diurnal rhythm of GCs secretion at 12 mo by collecting spontaneous 
fecal boli between ZT1-2 and ZT12-14 (i.e. immediately after the transition between the 
light and dark phases). The feces were collected in sterile Eppendorf tubes and stored at 
−80°C until further processing. Samples from each mouse (N=8–10 per group) were 
collected on two occasions (7-day interval between samplings). The concentration of 
corticosterone metabolites in dry fecal extracts was measured by enzyme immunoassay 
according to the manufacturer’s instructions (DetectX, Arbor Assays, Ann Arbor, MA, 
USA). 
Figure  3-1 Lissajous figures result from the 
composition of two phase-locked sinusoids. 
(A) Depiction of variations over time using a 
common timeline (phi = phase difference). 
Four samples with discrete distribution over 
time are shown as 1-4. (B) The state portrait is 
constructed by plotting the sampled values on 
orthogonal axes. The orthogonal projection of 
the sinusoids describe an ellipse. The 
orientation of the major axis and the direction 
of rotation (order of sampling points) depend 
on phi. Note that time of sampling is not 
included in the state portrait as an independent 
axis. 
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3.4 RETROVIRUS MEDIATED LABELING OF NEWBORN NEURONS IN THE 
HIPPOCAMPUS 
There are two regions in the adult brain where the neurogenic potential is retained: the 
subventricular zone (SVZ) (lining the medial aspect of the basal ganglia), and the 
subgranular zone (SGZ) of the DG. While the functional role of adult neurogenesis in 
humans is still debated, experimental evidence clearly links alterations in learning and 
mood with alterations in hippocampal neurogenesis. In rodents, the progenitor cells in the 
hippocampal neurogenic niche are generated at specific developmental age (GD14) and are 
preserved throughout life in a quiescent state (Clarke and Van Der Kooy, 2011). They 
respond to environmental cues and endogenous programming to provide functional, adult 
born neurons. One of the main objectives of this thesis was to characterize the 
morphological alteration in the mature granule cells of the hippocampus of DEX-exposed 
mice. In our model, the exposure to DEX in utero starts at GD14, i.e. the time the 
progenitor cells in the neurogenic niche are generated. The importance of neuronal integrity 
resides in the functional impact on the brain regions they innervate.  
From the first use of the Golgi staining from Santiago Ramón y Cajal, alternative methods 
have been used for morphological studies of the brain at cellular level. A further step 
towards the description of neuronal population subtypes was the application of 
immunohistochemical techniques aimed at imaging neuronal structures relying on the 
expression of neuronal markers (e.g. Calbindin or Tuj1-beta for immature post-mitotic 
neurons, DCX for neuroblasts, and NeuN for mature neurons). Nevertheless the limitations 
related to the diversity of neuronal populations and the heterogeneous timing of neuronal 
marker expression, together with the specific localization of the binding sites (e.g. nuclear, 
membrane-bound, or cytosolic), have made single cell morphological studies challenging. 
The application of virus-mediated gene transfer targeting specific neuronal cell populations 
(e.g. specific transgenic mouse lines) has facilitated the approach to morphologic and 
functional studies. The use of retroviral labelling in particular has enabled a new method of 
screening thanks to the possibility of selectively labeling proliferating cells, which allows 
morphological studies at virtually any stage of neuronal maturation. In this thesis we have 
used a retroviral vector based on Moloney murine leukemia virus, created from the 
transfection of capside (CMV-VsVg), viral proteins (CMVpg), and retroviral plasmid 
(CAG-GFP) (Naviaux et al., 1996). The CAG-GFP gene is a synthetic gene from Aequorea 
Victoria that produces green fluorescent protein (GFP). The retroviral vector is delivered 
through stereotactic injection and infects only dividing cells within 3 days post injection 
(Zhao et al., 2006). GFP is expressed in the entire neuronal structure and allows fine 
analysis of the morphological details. A detailed description of the methodology for 
retroviral particle production and use is described in Papers II and IV. The infected neurons 
acquire a morphology similar to pre-existing granule cell neurons by 28 days after fate 
specification (see (van Praag et al., 2002; Zhao et al., 2006)) making this method particularly 
suitable for the study of a homogeneous population of mature granule cells representative 
for the totality of the adult granule cells in the DG. The injection site for 12 mo old mice 
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was calculated in order to reach the sub-granular zone of the DG in the intermediate portion 
of the hippocampus, along the dorso-ventral axis, by using the position of the bregma as 
reference (Paxinos and Franklin, 2004): antero-posterior, -2.6 mm; medio-lateral, +1.75 
mm; dorso-ventral, -2.0 mm (from dura).  
3.5 SAMPLE PREPARATION FOR IMMUNOHISTOCHEMICAL PROCEDURES 
Four weeks after the retrovirus infection, the mice were killed by an overdose of anesthetic 
(sodium pentobarbital, 150 mg kg
-1
) and perfused transcardially with ice-cold buffered 
saline followed by 4% paraformaldehyde. Each brain sample was post fixed with 4% 
paraformaldehyde and the two hemispheres were differentially processed as follows: the 
left hemisphere (not injected with virus) was cryoprotected with 15% sucrose, quickly 
frozen on dry-ice, and 20 μm thick sections were cut with a cryostat. The right hemisphere, 
which received the retroviral injection, was embedded in 5% TopVision™ Low Melting 
Point Agarose (Thermo Scientific, Wilmington, DE, USA) and cut in 70 μm thick coronal 
sections with a vibratome (Leica VT1000s) for confocal microscopy imaging. This 
procedure was optimized to maximize the use of samples and minimize the number of 
animals used for ethical considerations. 
3.6 ANALYSIS OF HIPPOCAMPAL NEUROGENESIS 
To investigate neurogenesis, we estimated the progenitor proliferation and the maturation 
of newly generated neurons in the DG by immunohistochemical methods. 
Two different approaches were used in this thesis: EdU positive and DCX positive cell 
counting. EdU labeling is a method based on the incorporation of 5–ethynyl–2′–
deoxyuridine (EdU; a thymidine analogue) into the DNA of mitotically active cells. 
Animals were injected i.p. with EdU (50 mg/kg) for one week before sacrifice. EdU was 
visualized in histological preparation with a fluorescent azide in a copper–catalyzed [3+2] 
cycloaddition (“Click” reaction) (Zeng et al., 2011) which doesn’t require DNA 
denaturation. Although used frequently for evaluation of adult neurogenesis, the method is 
not specific for neurogenesis since it labels every dividing cell (glial cells as well as 
endothelial cells from blood vessels). Couillard-Despres and colleagues proposed DCX 
immunohistochemistry as more specific for the evaluation of neurogenic rate as DCX labels 
only proliferating progenitors committed to neuronal lineage (Couillard-Despres et al., 
2005). Similarly, the expression of neuron-specific tubulin epitope lasts until maturation to 
adult neuron, when the NeuN expression takes over and characterizes the adult neuron 
population. Therefore the evaluation of adult neurogenesis by means of DCX staining 
provides a more accurate estimation of the number of newly generated neurons likely to 
survive until adulthood. In addition, the use of DCX staining prevents the need for daily 
intraperitoneal injections and therefore reduces the stress in mice. In study I and II both 
methods are used and show consistent results. For this reason we performed the 
neurogenesis evaluation presented in the last paper only by DCX staining. 
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3.7 ANALYSIS OF GR EXPRESSION 
The expression of GR was assessed by measuring the fluorescence intensity in the DG from 
immune-labeled sections. Sections mounted on SuperFrostPlus Microscope Slides (VWR 
International) and circled with Dako pen were air dried for 10 min at room temperature, 
rinsed in PBS for 10 min, and subsequently incubated for 2 h in 5% normal guineapig 
serum (NGS) or normal donkey serum (NDS) in 0.3% Triton in PBS (50 μl/section) . Slides 
were then incubated for 72 h in GR primary antibody (GR H-300, rabbit polyclonal, Santa 
Cruz Biotechnology. Inc 1:500) in 0.5% NGS and 0.3% Triton in PBS at 4ºC. After 3 
consecutive 5 min washes with PBS, the slides were incubated for 2 h with secondary Ab 
(Alexa 488) Donkey anti Rabbit (1:200 in 1% BSA and 0.3% Triton) at room temperature. 
After washing 2 times for 5 min with PBS, we applied nuclear staining with DAPI 
(1:10,000) for 5 min. After 3 washing of 5 min each slides were mounted with DAKO 
Fluorescent Mounting media. The intensity of the positive signal was estimated in the 
granule cell layer (manually delineated), and the background intensity was evaluated in the 
molecular and polymorph layers of the DG.  
3.8 IMAGING AND ANALYSIS 
For morphological analyses, all brain sections (12-15/brain) from the right hemisphere 
through the entire hippocampus were processed for free floating immunohistochemistry for 
GFP and NeuN. To assess the complexity of 28 days old granule cells, we imaged an 
average optical thickness of 50 μm (from the slice thickness of 70 μm). Z-series at 1 μm 
intervals were acquired with a Plan Apochromat 20x/0.75 objective, digital zoom 1.5, on a 
Zeiss ZEN 2009 LSM 510 META confocal system. A total of 5-12 cells were analyzed 
from each mouse. For the spine density evaluation, images of GFP-labeled dendritic 
processes at the outer molecular layer were acquired with z-series at 0.5μm intervals, Plan-
Apocromat 63x/1.4 Oil DIC, digital zoom 3. A total of 5 dendritic segments from each 
mouse were analyzed. All images were analyzed in FiJi (Schindelin et al., 2012). Images of 
dendritic arborization were deconvolved with Iterative deconvolve 3D plugin and manually 
traced with Simple Neurite Tracer plugin. The dendritic extension and number of 
intersections were obtained by automated Sholl analysis (Fig. 3-2).  
Sholl analysis counts the number of intersections between dendrites and equally spaced, 
concentric circles centered on the soma. The spine density was manually calculated on 
maximum intensity projections of z-series from dendritic segments. Confocal imaging and 
data quantification were done by the same person, who was blinded to the experimental 
conditions.  
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3.9 ANALYSIS OF GENE EXPRESSION IN THE HIPPOCAMPUS AND SCN 
Hippocampal samples, trimmed from 140 μm frozen coronal sections from the left 
hemisphere were collected and processed for RNA extraction. The SCN was dissected as a 
small piece of tissue on ventral extent of the brain section adjacent to the third ventricle, 
immediately dorsal to the optic chiasm. The accuracy of SCN dissection was confirmed by 
the high content of AVP mRNA, and extremely low AVP receptor V1b mRNA. RNA 
extraction was performed using FFPE RNA Purification Kit (Norgen Biotek, Montreal, 
Canada) according to the manufacturer instruction. Concentration of RNA was measured 
by NanoDrop 1000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). The 
RNA (1 µg template/sample) was reverse-transcribed into cDNA using 0.5 µg of oligo-dT 
primer according to the instruction of Maxima first strand cDNA Synthesis kit 
(ThermoFisher, Wilmington, DE, USA). Amplification reactions were performed on a QS5 
System (Thermo Scientific, Wilmington, DE, USA) using 1µl cDNA template, SYBR 
Green PCR MasterMix (ThermoFisher, Wilmington, DE, USA) and 0.2 µM of each primer, 
diluted in purified water to a total volume of 12.5 μl. The PCR cycle conditions were: 50ºC 
for 2min, 95ºC for 10 min, followed by 95ºC for 15s and the annealing temperature for 1 
min for 40 cycles. The specificity of the qRT-PCR reactions was evaluated by including a 
dissociation stage to the melting curve analysis. The data were analyzed by QuantStudio 5 
System (ThermoFisher, Wilmington, DE, USA). A table with primers, annealing 
temperatures, and length of amplification product is available in SI (Paper II). The 
expression values were normalized against the house-keeping gene hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) according to the following formula: ΔCT (difference 
threshold cycles) = CT of target gene-mean CT of housekeeping gene. The relative 
expression levels (ΔΔCT) were calculated as ΔΔCT = ΔCT exposed –ΔCT controls. To 
estimate the relative expression regulation we used the formula 2
-ΔΔCT
.  
Figure 3-2 Schematic depiction of the workflow for image acquisition and analysis. 
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3.10 EMBRYONIC CORTICAL NSC CULTURE AND EXPOSURE PROCEDURES 
Primary cultures of NSCs were prepared as described in paper III. The cells were obtained 
from embryonic cortices (n=6–8 per cell preparation) from timed- pregnant Sprague-
Dawley rats (Harlan Laboratories, The Netherlands) at GD15 and dissected in HBSS (Life 
Technologies, Carlsbad, CA, USA). The tissue was mechanically dispersed, and meninges 
and larger cell clumps were allowed to sediment for 10 min. The cells were plated at a 
density of 40 000 per cm
2
 on a dish pre-coated with poly-L-ornithine and fibronectin 
(Sigma-Aldrich, Stockholm, Sweden). The cells were maintained in N-2 medium enriched 
with 10 ng/ml basic fibroblast growth factor (bFGF; R&D systems, Minneapolis, MN, 
USA) added every 24 h. The medium was changed every other day to keep cells in an 
undifferentiated and proliferative state. The cells were mechanically passaged via scraping 
in HBSS. Afterwards, the cells were gently mixed in N-2 medium, counted, and plated at 
the desired density. Under these culture conditions, NSC doubling time was ~ 20 h. To 
investigate the heritable effects of DEX on proliferating NSCs, we exposed NSCs to DEX 
(1 μM) for 48 h, as described earlier. Parental (P1) cells were harvested at the end of the 
exposure. We then passaged the cells in presence of bFGF but in absence of DEX, to obtain 
daughter cells (D2 and D3). Mitotically heritable effects were investigated in D3 cells that 
had never been directly exposed to DEX 72 h after respective passaging. 
3.11 GENOMIC DNA EXTRACTION  
DNA was prepared using the XL GenDNA extraction module kit (Diagenode, Liège, 
Belgium) according to the manufacturer's instructions. Quality and quantity of DNA was 
measured using NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA) 
and Quant-iT PicoGreen dsDNA reagent and kits (Invitrogen, Paisley, UK). 
3.11.1 Extraction of RNA and DNA from DEX-exposed offspring   
Newborn mice exposed to DEX in utero were obtained by injecting pregnant dams as 
descried previously. PND3 pups were killed by decapitation and the brain was rapidly 
dissected on ice and stored at − 80°C until processing. Next, RNA and DNA were extracted 
from dissected cortices using RNA and DNA extraction kits as instructed by the 
manufacturer. RNA was used for the analysis of gene expression by qPCR, while the DNA 
was used for measuring global DNA methylation and hydroxymethylation as described 
below. 
3.11.2 DNA methylation and hydroxymethylation assay  
DNA was prepared using the GeneElute mammalian genomic DNA miniprep kit (Sigma-
Aldrich, Stockholm, Sweden) according to the manufacturer's instructions. DNA quality 
and concentration was measured by NanoDrop 1000 spectrophotometer (Thermo Scientific, 
Wilmington, DE, USA). Separately global DNA methylation (5-mC) and 
hydroxymethylation (5-hmC) were determined using two different quantification kits 
(Epigentek, New York, NY, USA). 
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3.11.3 Methyl-DNA immunoprecipitation sequencing, MBD-seq  
 DNA was sonicated using Bioruptor 200 (Diagenode, Liège, Belgium) at high frequency 
with 30 s off/ on cycles. The average length of sonicated DNA was 200 bp, which was 
determined by gel electrophoresis. We used 1.2 μg of sonicated DNA for subsequent MBD2 
enrichment using MethylMiner methylated DNA enrichment kit (Life Technologies, 
Carlsbad, CA, USA). Briefly, first 10 μl of Dynabeads (Life Technologies, Carlsbad, CA, 
USA) M-280 streptavidin were cleaned by 1 × bind/wash buffer and 3.5 μg of BMD-biotin 
protein was mixed with clean Dynabeads (Life Technologies, Carlsbad, CA, USA) on a 
rotating mixer for 1 h. Then DNA fragments were incubated with the coupled MBD-beads 
overnight at 4°C. After removing non- captured DNA as supernatant, captured DNA was 
isolated by NaCl gradient elution (0.5 and 1 M). The accuracy of the assay was confirmed by 
using kit-supplied control DNA. Isolation of hypermethylated (0.5 and 1M) and non-
methylated DNAs (supernatant) was confirmed by quantitative real-time PCR analysis using 
Tsh2b (methylation-specific primer) or Gapdh (non-methylation-specific primer (Diagenode, 
Liège, Belgium). The recovered DNA was quantified by Qubit (Invitrogen, Paisley, UK) and 
50 ng of immunoprecipited DNA was used for library preparation using a kit from New 
England Biolabs (NEB# E6240S/L, BioNordika Sweden AB, Stockholm, Sweden). 
Subsequently, the library was analyzed by HiSeq 2000, (Illumina Inc, San Diego, CA, USA). 
The sequence tags were then aligned to the rat genome (assembly rn4) with the Bowtie 
alignment tool (http://bowtie-bio. sourceforge.net/index.shtml). To avoid any PCR bias, we 
allowed only one read per chromosomal position. Next, the peaks (hypermethylated regions) 
were identified using MACS software (Szabo and Hoffman, 2012; Zhang et al., 2008) and the 
rat CGIs were downloaded from the UCSC database (http://genome.ucsc.edu). The genome-
wide DNA methylation levels were quantified by analyzing mapped sequencing reads as 
methylation peaks, using the supernatant of each sample as standard background and are 
referred to as total number of peaks. 
3.12 STATISTICAL ANALYSES  
All statistical analyses were performed in Statistica™ (Dell Inc. Tulsa, OK, USA). 
Immobility time in FST was analyzed using a mixed model ANOVA with repeated 
measures, followed by contrast analysis. Neurogenesis (number of DCX positive neurons) 
was analyzed using a factorial ANOVA model with interaction terms. Pairwise differences 
were tested independently using student’s t-test. Measures from traced neurons were 
averaged separately for each subject. For measures of number of branch point and dendritic 
extension a mixed ANOVA model was tested for the effect of the treatments. The differences 
between Sholl curves from each group were reported only when significant pairwise 
differences were found for each consecutive point (pairwise t-test). Gene expression was 
analyzed using one-sample t-test vs. “no-regulation” value (=1), followed by t-test between 
groups. Differences are reported as significant for p<0.05. The data are shown as average ± 
SEM. 
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4 RESULTS AND DISCUSSION 
4.1 MODEL ASSESSMENT 
The exposure to DEX from GD14 until delivery induced a mild but consistent decrease in 
intrauterine growth rate (Supplementary Fig. 1A in Paper I). After delivery, the bodyweight 
was lower in both male and female DEX-exposed mice. The difference was consistent until 
weaning (PND 21), but disappeared soon thereafter (no significant difference at PND 28; 
Supplementary Fig. 1B in Paper I).  
A battery of tests was run to assess early alterations in spontaneous behavior and anxiety 
related disorders. The behavioral outcomes of prenatal exposure to DEX, including 
hyperactivity in the open field and impaired social behavior in the social recognition test, 
were only present in the male offspring (Supplementary Fig. 2 in Paper I). The sex-
differences were in agreement with previous studies (Mueller and Bale, 2008; Weinstock, 
2007), therefore we used only the male offspring for the following experiments. The 
treatment with DEX did not affect mother’s behavior measured as maternal care, which if 
altered, could represent a confounding factor in the interpretation of expected late onset 
alterations in the offspring. The pup retrieval test was performed at PND 4, upon returning 
the pups to the cage after culling. The test showed no differences between mothers injected 
with DEX and controls in the quality of nest building, time spent in the retrieval of the litters 
to the nest and time spent in nursing. Therefore we can assume that behavioral alterations 
reflect the persistent effects of developmental exposure to DEX, and are not significantly 
influenced by differences in maternal behavior.  
4.2 LATE ONSET DEPRESSION-LIKE BEHAVIOR 
We tested male offspring in the FST at several ages, and found that DEX-exposed mice 
showed increased immobility time at 12 mo, but not earlier (Fig. 1 in Paper I). The 
depression-like phenotype was confirmed in the tail suspension test (Supplementary Fig. 3, in 
Paper I). This result was in agreement with previous findings on affective disorders resulting 
from prenatal exposure to excess GCs in rodents, although differences in timing of onset and 
sex appear to be related to the animal model, dose of DEX and timing of exposure (Hauser et 
al., 2009; Liu et al., 2012; Welberg et al., 2001; Wyrwoll and Holmes, 2012). Nevertheless 
HPA axis malfunction in the stress response is a common denominator.  
4.3 ALTERATIONS IN NEUROGENESIS  
We investigated neurogenesis at 12 mo of age and observed that DEX-exposed mice had a 
lower number of EdU-positive cells in the SGZ (Fig. 2A in Paper I) and less DCX-positive 
cells in the granular layer of the DG (Fig. 2B in Paper I). The count of DCX-positive cells 
throughout the DG has been shown to provide an accurate estimate of hippocampal 
neurogenesis rate (Couillard-Despres et al., 2005). In our studies we found a consistent 
similar proportion between EdU and DCX-positive cells counts, therefore we adopted DCX 
staining as preferential method for neurogenesis assessment. Recent studies in rodents have 
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pointed out a functional segregation of the hippocampus along the dorso-ventral axis (Wu 
and Hen, 2014) attributing to the ventral portion a preferential involvement in emotional 
related functions (Leary and Cryan, 2014) and higher sensitivity to GCs (Workman et al., 
2015). A preferential action of antidepressants on ventral hippocampus neurogenesis is also 
suggested (Leary and Cryan, 2014). When we analyzed the effects of DEX along the 
longitudinal axis of the DG we did not find clear dorso-ventral gradients in neurogenesis 
(Supplementary Fig. 1 in Paper II), as the decrease in neurogenesis was uniformly distributed. 
Neurogenesis is a complex process initiated by the activation of quiescent neuronal 
progenitor cells, and involving gene expression changes, extracellular signaling, neurotrophic 
factors, neurotransmitters, and epigenetic modifications (Schafer and Gage, 2016). From the 
genes known to regulate neurogenesis we selected those that are deregulated in depression 
models and differentially regulated by antidepressants. Notably, some of the selected genes 
showed persistent alterations in DNA methylation in NSC cultures, as well as cortices from 
PND3 pups exposed to DEX (Paper III).  
The decrease in neurogenesis in DEX-mice was associated with up-regulation of p16 and 
Cdkn1c, and down-regulation of Klf15 (Krüppel-like factor), three relevant genes known to 
play key roles in neurogenesis. The cyclin-dependent kinase inhibitor p16 needs to be 
repressed to maintain the proliferative state of neuronal progenitors, and its up-regulation is a 
marker of cell senescence (Stein et al., 1999). Interestingly, p16 is persistently up-regulated in 
NSC cultures exposed to DEX (Bose et al., 2010). Cdkn1c, another cyclin-dependent kinase 
inhibitor which has growth inhibitory properties (Boonen et al., 2016), is expressed in 
quiescent progenitor cells and immature neurons and promotes cell cycle exit in NSCs 
(Furutachi et al., 2013). Klf15 a transcription factor expressed in the ventricular zone during 
brain development that regulates neuronal differentiation at late stages, inhibits neuronal 
differentiation when overexpressed, contributing to the maintenance of the NSC population at 
late embryonic stages (Ohtsuka et al., 2011). This pool of genes was part of a broader list of 
genes generated by high throughput sequencing of immune-precipitated methylated DNA 
obtained from NSC exposed to DEX in vitro (see Paper III). The up-regulation of p16 and 
Cdkn1c and the down-regulation of Klf15 in concert could trigger the impairment in 
hippocampal neurogenesis observed in DEX-exposed mice that develop depression-like 
behavior. In our experiments, we isolated RNA from tissue homogenates obtained from the 
entire hippocampus. Therefore the results cannot be ascribed specifically to the adult-born 
granule cells, but reflect the expression in other cell populations as well. However it should 
be noted that some genes like Cdkn1c are uniquely expressed in the quiescent progenitors and 
immature neurons in the DG of the hippocampus (Furutachi et al., 2015, 2013). Further 
analyses at single cell level (such as promoter methylation) in vivo should be considered to 
specifically address the epigenetic changes induced by DEX exposure. 
4.3.1 Alterations in neurogenesis in vitro 
NSCs show persistent alterations in proliferation and differentiation following DEX exposure 
(Bose et al., 2010). In addition, they display global DNA hypomethylation, suggesting the 
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involvement of epigenetic changes. To further investigate the mechanisms of epigenetic 
modifications induced by DEX, we analyzed the genome-wide DNA methylation pattern in 
proliferating NSCs isolated from rat embryos. Parent (P1) NSCs, i.e. directly exposed to 
DEX, and daughter cells (D3), i.e. never directly exposed to DEX, exhibited stable alterations 
in DNA methylation: about 64% of the methylated peaks were preserved between P1 and D3 
(Fig.1 in Paper III). The hypermethylated DNA sequences were located in promoter regions 
of genes known to regulate cell proliferation, differentiation, migration, and cell senescence 
(Supplementary tables S10 and S11 in Paper III) like FOXO3a, Cdkl5 and Gsk3b. In 
agreement with these results, the expression of enzymes regulating DNA methylation, such as 
Dnmt3a and Tet3 was altered. We further investigated the role of GR signaling and found 
that a key alteration was the GR-dependent Tet3 down-regulation. The functional relevance 
of Dnmt3a and Tet3 regulation was confirmed by the changes in 5-mC and 5-hmC levels. We 
validated these mechanisms in vivo by analyzing cerebral cortices isolated from PND 3 
mouse pups exposed to DEX in utero. Similar to NSCs in culture, the Dnmt3a down-
regulation and Tet3 up-regulation were accompanied by a decrease in 5-mC and an increase 
in 5-hmC levels. These data provide an indication about the class of genes most probably 
involved in the alterations observed in vivo.  
4.4 ALTERATIONS IN NEURONAL MORPHOLOGY 
Decreased complexity in dendritic arborization has been described in experimental models of 
depression, as well as in post-mortem material collected from depressed patients (Llorens-
Martín et al., 2016; Qiao et al., 2016; Ren et al., 2015), and there is evidence that effective 
antidepressant treatments are accompanied by restoration of dendritic arborization (Morais et 
al., 2014; Seo et al., 2014). To investigate the effects of DEX on the morphology of newly 
generated neurons, we used retrovirus-mediated labeling with GFP. The neurons in the 
granule cell layer of DEX-exposed mice displayed an overall decrease in the dendritic 
arborization complexity, as measured by the total dendrite extension and number of terminal 
dendrites (Fig. 3A in Paper II). In addition, the dendritic alterations were accompanied by a 
decrease in spine density on distal dendritic segments (Fig. 3B in Paper II). 
We further investigated the qualitative alterations in dendritic arborization by means of Sholl 
analysis (Fig. 3C in Paper II). We found that DEX-exposed mice have a higher number of 
crossings in proximal segments (between 10 and 50 µm from the soma, where the primary 
dendrites are localized), but a lower number of crossings in the distal region (between 90 and 
260 µm from the soma, where terminal dendrites are localized) as compared to controls. The 
configuration of dendritic arborization that we found in DEX-exposed mice (i.e. enhanced 
proximal branching, but lower number of terminal dendrites) is consistent with a V-shape 
phenotype (Llorens-Martín et al., 2016), in contrast to the more common Y-shape (see Fig. 
4A in Paper II; Fig. 4-1). 
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We assessed the occurrence of V-shaped neurons and found that DEX-exposed mice 
displayed about 1/2 V-shaped neurons, as compared to about 1/4 in controls (Fig. 4B). A high 
frequency of neurons with a V-shaped phenotype has been described so far only in severe 
disorders, namely in post-mortem brain from Alzheimer’s Disease patients (Einstein et al., 
1994; Flood et al., 1987), or in experimental models of neuroinflammation (Lee et al., 2015; 
Llorens-Martín et al., 2016). This conformation is therefore probably indicative of severe 
disorders and can potentially lead to hippocampal function impairment (McAllister, 2000). In 
V-shaped neurons, recurrent excitatory connections from CAF are more frequent than in Y-
shaped neurons (Förster et al., 2006). Conversely, entorhinal cortex inputs, which normally 
contribute to the dendritic maturation of granule cells, reach fewer distal dendrites as 
compared to Y-shaped neurons (Frotscher et al., 2000). Therefore, the V-shaped morphology 
favors excitatory signals from the ipsilateral and contralateral granule cells over those from 
the EC. This arrangement is reminiscent of the epileptic condition in which mossy fiber 
collaterals establish aberrant synapses with granule cell dendrites. It has been proposed that 
these aberrant projections alter the balance between inhibitory and excitatory input to the DG. 
However, we did not find malpositioning of granule cells in the DG, which typically 
accompany epilepsy (Förster et al., 2006).  
Neuronal morphology of adult born neurons responds to intrinsic programming in the initial 
stages, as well as neurotransmitter-programming mechanisms and molecular signaling from 
the pre-existing neuronal architecture. The expression of genes regulating neuronal 
maturation is not restricted to neuronal precursors, but is found also in adult neurons and non-
neuronal cells (e.g. astrocytes (Terrillion et al., 2017)). In addition, the transition to more 
mature and excitatory granule cells with higher dendritic tree complexity is regulated by 
Figure 4-1 Illustration of Sholl analysis. The number of 
intersections between the concentric spheres and the dendritic 
tree are plotted as a function of distance from the soma to 
generate the Sholl curves. Qualitative differences between Y-
shaped and V-shaped phenotypes (bottom panels) are readily 
depicted by distinctive Sholl curves (top panel).  
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innervation from extra-hippocampal regions (e.g. EC) and intra-hippocampal inter-neuronal 
fibers (Crowther and Song, 2014; Frotscher et al., 2000). Variations in morphology of new-
born granule neurons are not only dependent on physiological conditions but also on 
detrimental stimuli such as stress, dietary factors and drugs of abuse, as extensively reviewed 
by Llorrens-Martìns and colleagues (Llorens-Martín et al., 2016). Post-mitotic regulation in 
the expression of several plasticity related genes characterize the highly dynamic adaptations 
that granule cells, together with pyramidal cell population from CA implement in order to 
properly respond to the ever-changing environment or to insults of various nature. In the 
screening for genes likely to be involved in the alteration observed we selected some of those 
known to be sensitive to GCs excess and also responsive to antidepressant treatment.  
We found that the expression of TrkB (receptor for BDNF; (Li et al., 2009; Martínez et al., 
1998)), disrupted in schizophrenia 1 (DISC1; regulator of dendritic arborization), and GAP-
43 (regulator of cell cycle, neuronal differentiation, maturation and plasticity (Mani et al., 
2001; Zhao et al., 2009)) was down-regulated in DEX-mice. The alterations in morphology in 
DEX-mice are consistent with the down-regulation of GAP-43 and TrkB expression. GAP-43 
regulates neuronal differentiation and dendritic growth (Chao et al., 1992; Mani et al., 2001; 
Yaniv et al., 2008; Zhao et al., 2009), and has been shown to be down-regulated in post-
mortem brain of patients with MDD (Müller et al., 2001). Moreover, its expression has been 
shown to be up-regulated following antidepressant treatment with imipramine (Sairanen et 
al., 2007; Yaniv et al., 2008).  
DEX exposure was also associated with downregulation of Reelin (Reln) a glycoprotein 
regulating granule cells’ migration in DG and dendritic complexity (Förster et al., 2006). The 
alterations in the pattern of dendritic arborization of granule cells in DEX-mice are 
compatible with the down-regulation of DISC1 and Reln. Both genes are highly expressed in 
the adult hippocampus, where they regulate the maturation of new-born granule cells, and 
have been associated with psychiatric conditions such as schizophrenia (Kempermann et al., 
2008) and depression (Lussier et al., 2013). DISC1 appears to be particularly relevant in our 
model, because DISC1-Q3IL mutant mice display depression-like behavior and treatment 
with FLX or DMI ameliorates the phenotype (Lipina et al., 2012). In addition, DISC1 down-
regulation increases the number of primary dendrites (Lee et al., 2015), thereby promoting 
the occurrence of V-shaped granule cells (Llorens-Martín et al., 2016). Similarly, the down-
regulation of Reln in the DG has been proposed as a mechanism through which GCs lead to 
progressive development of depression like behavior (Fenton et al., 2015).  
A particularly relevant finding in relation to the lack of response to FLX is the down-
regulation of TrkB gene expression in the hippocampus of DEX–exposed mice. BDNF 
(whose expression is not altered in our model; unpublished data) stimulates neurogenesis via 
the TrkB receptor by activating the MAPK/CREB pathway (Li et al., 2009). While the 
response to antidepressants is typically associated with BDNF up-regulation (Lindholm and 
Castrén, 2014), TrkB knock-out mice display impaired neurogenesis and SSRI-resistant 
depression (Li et al., 2009; Yan et al., 2016) similar to our DEX-exposed mice. TrkB is also 
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required for proper hippocampal innervation by commissural axons, as well as for 
synaptogenesis and maturation of hippocampal connections (Martínez et al., 1998).  
4.5 ANTIDEPRESSANT TREATMENT 
We selected FLX based on our previous study (Onishchenko et al., 2008) and on the 
established effectiveness of SSRIs in models of depression induced by prenatal stress 
(Nagano et al., 2012; Rayen et al., 2011). Treatment with FLX for 21 days before repeating 
the FST did not affect the immobility time in DEX-exposed mice, and did not have any 
significant effect on neurogenesis. 
It has been previously shown that the effect of FLX on depression and neurogenesis requires 
rhythmic corticosterone secretion in rodents, suggesting that alterations in HPA axis 
regulatory loop known to be associated with prenatal stress, may contribute to FLX failure 
(Huang and Herbert, 2006). Indeed, when we investigated the diurnal rhythm of GCs 
secretion by measuring the concentration of GCs metabolites in feces DEX-exposed mice 
exhibited lower levels of corticosterone metabolites and did not show significant diurnal 
oscillations (Fig. 2C in Paper I).  
HPA axis regulation, including the circadian fluctuations in GCs secretion, involves 
hippocampal GR expression in the feedback loop (Jankord and Herman, 2008; Sapolsky et 
al., 1984). Twelve month-old DEX-exposed mice display significant downregulation in 
hippocampal GR expression (Fig. 2D and Supplementary Fig. 4 in Paper I), in agreement 
with earlier reports (Levitt et al., 1996; Welberg et al., 2001). 
The SNRI antidepressant DMI has been previously shown to be effective in depression 
models resistant to FLX (Guo and Lu, 2014; Holmes et al., 2002; Yu et al., 2012). Both FLX 
and DMI have been reported to restore neurogenesis (Chen et al., 2006; Guirado et al., 2012) 
as well as the complexity of dendritic arborization and the density of dendritic spines in the 
hippocampus (Laifenfeld et al., 2002; Norrholm and Ouimet, 2000). Unlike FLX, which 
relies on rhythmic GR activation for its antidepressant effects (Huang and Herbert, 2006), 
DMI enhances GR nuclear translocation and gene transcription via a steroid-independent 
mechanism (Chen et al., 2001; Huang and Herbert, 2006). In addition NE-receptor mediated 
intracellular cascades have been described to promote neurogenesis, proliferation and neurite 
growth by regulating the expression of genes involved in neuronal sprouting and 
differentiation (Laifenfeld et al., 2002).  
When we re-tested the mice for FST after 4 weeks of treatment with DMI, the immobility 
time was decreased significantly only in DEX-mice (Fig. 1 in Paper I). We also observed that 
DMI increased the number of DCX-positive neurons in DEX-exposed mice (Fig. 2 in Paper 
II). The restoration of neurogenesis to control levels was accompanied by Cdkn1c, p16 and 
Klf15 normalization (see Fig. 5 in Paper II). Interestingly, the expression of Mbd1 (which, 
together with BMi1 and MLL1, controls the timing of cell cycle exit and initiates neuronal 
differentiation in the adult brain (Mateus-Pinheiro et al., 2011)) was not affected by DEX, but 
up-regulated by DMI treatment only in DEX-mice. Adult neurogenesis is epigenetically 
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regulated by a battery of genes like Mbd1. Mbd1 binds the promoter region of the gene 
encoding the mitogen Fibroblast Growth Factor 2 (FGF2), controlling its expression in NSC 
and regulating the exit from proliferative cycle towards differentiation (Mateus-Pinheiro et 
al., 2011). DMI promoted Mbd1 up-regulation, which could contribute to the positive effects 
on neurogenesis observed in the DEX-exposed mice after DMI treatment. 
DMI also had a remarkable impact on the adult-born granule neurons morphology. After 
DMI treatment, the proportion of V-shaped phenotype decreased to control levels in DEX-
exposed mice, while no significant changes were detected in controls (Fig. 4 B in Paper II). 
Overall, the effects of DMI on spatial distribution of dendritic arborization and spine density 
(see also Supplementary Fig. 2 in Paper II) were associated with a differential regulation of 
the plasticity related genes analyzed. Indeed we found that the expression of GAP-43 and 
TrkB is restored to control levels after DMI treatment in DEX-exposed mice. Although no 
direct interaction of NE and TrkB has been reported, Yaniv et al. describe that the activation 
of alpha2-adrenergic receptors by NE induces the expression of plasticity related genes (e.g. 
GAP-43) through the MAPK/ERK/CREB pathway (Yaniv et al., 2010, 2008). Thus, the 
restoration of neurogenesis and dendrite growth by DMI can be the result of TrkB-mediated 
and NE signaling converging on CREB activation.  
4.6 CIRCADIAN RHYTHM ALTERATIONS 
4.6.1 Alterations in circadian entrainment of spontaneous activity 
4.6.1.1 Rhythmicity in spontaneous activity 
Spontaneous activity is mainly regulated by circadian photic entrainment and requires 
metabolic proper response in order to predict regular cyclic changes in the environment to the 
internal clock. The diurnal fluctuation in GCs serve this fundamental hormonal adaptations 
(Kiessling et al., 2010; Weibel et al., 2002). Therefore we asked whether the blunting in GCs 
fluctuation in DEX-mice could reveal anomalies in circadian entrainment in steady-state 
conditions (LD cycle or DD), as well as in response to circadian re-entrainment (restoration 
of LD after DD; forced synchronization; Fig. 3A in Paper I). In spontaneous activity, this is 
illustrated by the acrophase (the time at which the peak of a rhythm occurs (Cornelissen, 
2014)) occurring before ZT 18 (i.e. the middle of the dark phase) in the context of steady 
entrainment with 24 h circadian period. In contrast, forced synchronization transiently 
increases the amplitude of circadian oscillations and delays the acrophase to around ZT 18. 
DEX-exposed mice displayed larger amplitude than controls during steady entrainment 
already from 1 mo of age, and showed no significant difference between steady entrainment 
and forced synchronization (Fig. 3B in Paper I). The acrophase in DEX-exposed mice 
occurred close to ZT 18 at all ages tested, and was significantly delayed by forced 
synchronization only at 1 mo (Fig. 3C in Paper I). On the other hand, the acrophase of 
spontaneous activity in control mice occurred consistently before ZT 18 under steady 
entrainment conditions, and was significantly delayed by forced resynchronization at 1, 3, 
and 5 mo (Fig. 3C in Paper I). This suggested that photic entrainment has a particularly 
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strong effect in DEX-exposed mice. Moreover, the onset and offset of active phase virtually 
coincided with the onset and offset of the dark phase (Fig. 3D in Paper I). Therefore, DEX-
exposed mice appear to have shorter active phase duration at all ages tested (Fig. 3E in Paper 
I).  
4.6.1.2 Variability in spontaneous activity 
The central clock, located in the SCN controls the intrinsic rhythmicity in spontaneous 
activity at multiple timescales (i.e. circadian as well as ultradian oscillations) (Hu, 2009; Hu 
et al., 2012). The variability of spontaneous is an intrinsic feature of the regulation of 
spontaneous activity by the SCN, and should therefore not vary significantly between any 
two steady-state conditions (e.g. free-running and constant LD cycle).  
In our model, the mice exposed to DEX tend to have higher scaling exponent under constant 
photic entrainment (LD), which suggests with a pattern where diurnal fluctuations are the 
dominant cyclic component. Abrupt transitions between steady states induce transient 
changes in scaling exponent, presumably due to a strong diurnal rhythm (see Fig. 5B in Paper 
I). This effect reach significance in controls only at the ages of 1 and 3 mo, while in DEX-
exposed mice it was consistently detected at all ages tested. In contrast, DEX-exposed mice 
displayed consistently higher scaling exponent under constant photic entrainment as 
compared to free-running conditions. This is consistent with a pattern of activity dominated 
by diurnal fluctuations and lead to the investigation of the response to an abrupt change in LD 
cycle.  
4.6.2 Phaseshift challenges the ability to re-entrain 
We analyzed the spontaneous activity in response to a 6 h phase advance at the age of 6 mo 
(Fig. 4A in Paper II). It is worth to mention that the transition to dark allows, but does not 
trigger the onset of activity, in contrast to light onset, which suppresses the activity and 
directly resets the central clock (Challet, 2007; Golombek and Rosenstein, 2010). Thus, 
advancing the onset of the dark challenges the ability of mice to re-entrain. 
We observed that the acrophase is advanced by 6 h immediately after the phase advance in 
the LD cycle (Fig. 4B in Paper I). When we analyzed the onset and the offset of the active 
phase in relation to the LD cycle we found that the onset of active phase coincides with the 
beginning of the dark phase immediately after the phase advance of the LD cycle in DEX-
exposed mice. In contrast, the onset of activity is lagging behind the onset of the dark phase 
in control mice (Fig. 4C in Paper I; Fig. 1C in Paper IV). We confirmed these findings in 
subsequent phaseshift experiments, where we show that DEX-mice typically re-entrain 
within 1 day after the phase advance, as compared to about 3 days in controls (Fig. 1C in 
Paper IV). Altogether, these data suggest that the diurnal rhythms in spontaneous activity in 
DEX-exposed mice are more rigid in relation to the LD cycle. 
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4.6.3 Synchronization of peripheral oscillators by AVP 
We analyzed the expression of core clock genes Bmal1 and Per1 in SCN samples from 
animals killed at the peak and at the trough of their expression (i.e. early subjective day and 
early subjective night (Ono et al., 2017). DEX-exposed mice displayed robust circadian 
fluctuations in Bmal1 and Per1mRNA expression, similar to controls (Fig. 2A in Paper IV). 
This confirmed that the alterations in entrainment of spontaneous activity in DEX-exposed 
mice are due to altered photic entrainment, and not to SCN dysfunction in clock genes 
regulation.  
AVP is the main output from SCN (Kalsbeek et al., 2010) and plays a critical role in driving 
peripheral oscillators, as well as other brain regions, including the hippocampus, through 
HPA axis rhythmic activity (Buijs et al., 1999). Within the SCN, AVP signaling is critical for 
the synchronization of neuronal firing patterns, and decreased AVP signaling in the SCN 
renders the self-sustained oscillation more sensitive to perturbations, such as photic re-
entrainment (Yamaguchi et al., 2013). Accelerated re-entrainment (“resistance to jet-lag”) has 
been described in models of impaired AVP signaling in the SCN (Mieda et al., 2015; Tsuji et 
al., 2017; Yamaguchi et al., 2013). We measured the expression of AVP and we found it was 
down-regulated in DEX-mice, both at the peak, and at the trough of its expression (Fig. 2B in 
Paper IV).  
This observation indicates that a decrease in AVP signaling could reflect a decreased drive on 
HPA axis as well as on hippocampus as part of the stress response system. To confirm our 
hypothesis we measured GR expression in the hippocampus and found a down regulation in 
DEX-exposed mice. Moreover, the analysis of clock gene expression in the hippocampus 
revealed a reduction in circadian oscillations and a phase de-synchronization of Bmal1 
expression from SCN oscillations. This is supported by the state portraits (Fig. 3B in Paper 
IV), which show that naïve DEX-exposed mice do not display a pattern reminiscent of 
coupled oscillations. 
4.6.3.1 Clock genes expression and hippocampal neurogenesis 
Oscillations in circulating GCs control hippocampal neurogenesis also by driving the 
expression of clock genes, particularly Bmal1 and Per1 (Bouchard-Cannon et al., 2013; 
Conway-Campbell et al., 2010; Kimiwada et al., 2009; Segall and Amir, 2010). We observed 
that the expression of clock genes in the hippocampus is altered in depressed DEX-exposed 
mice (i.e. at the age of 12 mo) (Fig. 2E in Paper I). Interestingly similar alterations in clock 
gene expression were also displayed at 3mo of age. We further refined the analysis of clock 
gene expression, and investigated the synchronization of a core clock gene (Bmal1) between 
the DEX and control running under the same LD conditions. We sampled hippocampi at 
different time points to depict the discrete distribution of expression over time. The analysis 
of coupling was performed by plotting the relative expression of Bmal1 (Fig. 3A; Paper IV) 
within the different groups while accounting for the temporal sequences of sampling. Bmal1 
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expression in DEX-exposed mice was substantially different from controls, (Fig. 3 in Paper 
IV) suggesting a different pattern of Bmal1 expression under the same LD conditions.  
4.6.4 DMI treatment restores entrainment in DEX mice 
Chronic light deprivation apparently impairs specifically the NE- LC system (Gonzalez and 
Aston-Jones, 2008), and DMI is effective in reversing the behavioral effects associated with 
light deprivation (González and Aston-Jones, 2006). In addition, selective pharmacological 
lesion of NE projections from LC have a significant effect on circadian rhythms only in 
steady entrainment (i.e. constant LD cycle), but not in free-running (i.e. constant darkness, 
DD) conditions (González and Aston-Jones, 2006). This suggests that NE modulates diurnal 
entrainment rather than altering the intrinsic SCN function. Naïve DEX-exposed mice re-
entrain within 1 day after the phase advance, as compared to about 3 days in controls (Fig. 
1B, C in Paper IV), and re-entrainment was delayed in DEX-exposed mice after 28 days of 
treatment with DMI (Fig. 1B, C in Paper IV).  
For psychiatric disorders, the proposed mechanism is the desynchronization of molecular 
clocks from the SCN, rather the dysfunction of SCN per se (Bering et al., 2017; Li et al., 
2013; Menet and Rosbash, 2011) (reviewed recently by (Schibler et al., 2015)). Here we 
show that the expression of core clock gene Bmal1 in the hippocampus and the SCN is 
desynchronized in mice exposed to DEX in utero (Fig. 3 in Paper IV), which may account for 
the blunted oscillations in clock genes in the hippocampus of depressed mice (Paper I). We 
found that the synchronization of the hippocampal clock with the SCN was recovered after 
DMI treatment (Fig. 3 in Paper IV). The HPA axis regulatory loop is required for the 
synchronization of slave oscillators with the SCN (Kalsbeek et al., 2010). In DEX-exposed 
mice, DMI treatment potentiated the drive of SCN on HPA axis by up-regulating AVP 
expression in the SCN (Fig. 2C in Paper IV; see also (Cagampang et al., 1994; Vacher et al., 
2003)), and increased the hippocampal sensitivity to CGs signaling by up-regulating the 
expression of GR (Fig. 2D in Paper IV). Notably, chronic DMI treatment has a direct effect 
on GR up-regulation, translocation and steady-state levels in the hippocampus (Lai et al., 
2003; Okugawa et al., 1999; Paul Rossby et al., 1995), suggesting that DMI treatment may 
have persistent effects.  
4.7 DMI TREATMENT PREVENTS THE ONSET OF DEPRESSION 
We tested the possibility to intervene at early stages of circadian alterations in order to 
prevent the occurrence of depression-like behavior at 12 mo. Therefore we tested whether 
antidepressant treatment with DMI at 6 mo could prevent the onset of depression-like 
behavior and the associated alterations in hippocampal neurogenesis that DEX-exposed mice 
develop at 12 mo. 
Treatment with DMI at 6 mo prevented the increase in immobility time at 12 mo in DEX-
exposed mice (Fig. 4 in Paper IV). Similarly, neurogenesis in 12 mo-old mice treated with 
DMI at the age of 6 mo was not decreased as compared to controls (Fig. 5B in Paper IV). In 
DEX-exposed mice treated with DMI also the proportion of V-shaped neurons and the 
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pattern of dendritic arborization were not different from controls (Fig. 5E in Paper IV). The 
steady effects of DMI on GR expression and activity (Lai et al., 2003; Okugawa et al., 1999; 
Paul Rossby et al., 1995) could provide a mechanism for the long-term protective effect of 
DMI. The hippocampal expression of GR was up-regulated following DMI treatment at 6 
mo, therefore we can speculate that the persistent up-regulation of GR leading to the 
restoration of coupling between molecular clocks plays a critical role in preventing the onset 
of depression in DEX-exposed mice.  
4.8 IMPAIRED ENTRAINMENT IS ALSO PRESENT IN PRIMARY SKIN 
FIBROBLASTS 
Fibroblasts isolated from adult DEX-exposed mice displayed smaller amplitude of 
oscillations in Bmal1 mRNA expression (Fig. 5C in Paper I). This indicates that while the 
expression of Bmal1 can be synchronized across the fibroblast cell population, the cross-
synchronization dissipated faster in the fibroblasts derived from DEX-exposed mice, and is 
consistent with the facilitated circadian re-entrainment we observed in spontaneous activity.  
In a preliminary experiment, we found that fibroblasts harvested from DEX-mice treated with 
DMI showed amplitude of oscillations in Bmal1 mRNA expression similar to controls (Fig. 
4-2). This result confirmed the efficacy of DMI to restore the ability of the molecular clock 
machinery to entrain to external synchronizing stimuli. 
Figure 4-2 Oscillations in Bmal1 expression in primary skin fibroblasts. The cells were isolated form skin 
samples collected from mice (N=3-4/group) aged 6 mo. The expression of clock genes was synchronized with 
a pulse of DEX, and the time of harvesting is indicated on the horizontal axis. The data points are double-
plotted to visualize the circadian pattern of fluctuations. The amplitude of oscillations was estimated using 
COSINOR analysis (right panel). The amplitude in Bmal1 expression oscillations was decreased in 
fibroblasts isolated from naïve DEX-exposed mice, but was restored to control levels in cells isolated from 
DEX-exposed mice treated with DMI.  
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5  CONCLUDING REMARKS 
Epidemiological and experimental studies have shown that alterations in the intrauterine 
programming occurring during critical periods of development have adverse consequences in 
later life. Unfavorable prenatal factors induced by stress, childhood abuse/neglect or exposure 
to neurotoxic food contaminants, can cause epigenetic changes in early life, which may lead 
to mood disorders in adulthood, as shown in humans and rodents. Specifically, clinical 
studies have shown a correlation between intrauterine growth retardation, which is commonly 
associated to high levels of GCs glucocorticoids, and the development of ADHD and 
depression. The general objective of this thesis project was to investigate the long term 
consequences of a deranged prenatal hormonal milieu induced by excess glucocorticoids. 
Using mice exposed to DEX in utero as experimental model, we found that prenatal exposure 
to DEX induces late onset depression-like behavior in 12 mo old male mice, associated with 
impaired adult neurogenesis and morphological alteration of adult born granule cells in the 
hippocampus. Concordantly, the expression of relevant genes controlling neuronal plasticity 
in the hippocampus is also altered, likely due to epigenetic modifications. DEX-exposed mice 
also display blunted oscillations of circulating corticosterone and decreased GR expression in 
all hippocampal cell subpopulation. Moreover, DEX induces alterations in circadian 
entrainment of spontaneous activity, which appear long before the onset of depression-like 
behavior. Along with the abnormal entrainment, the coupling of oscillations in the expression 
of core clock genes between the SCN and the hippocampus is also disrupted.  
In the attempt to reverse the depression-like phenotype, we tested two different classes of 
antidepressants: SSRI (FLX) and SNRI (DMI). FLX treatment has no effect on depressed 
DEX mice, probably as a consequence of weaker glucocorticoids oscillations. In contrast, 
DMI has a positive effect not only on depression-like behavior, but also on neurogenesis and 
neuronal morphology. The mechanism behind the effects of DMI may be linked to the 
enhanced GR function facilitating GCs intracellular transportation and GR nuclear 
translocation, as well as the restoration of TrkB gene expression. DMI also promotes the 
restoration of circadian entrainment of spontaneous activity, which is associated with a 
normalization of AVP expression in the SCN, as well as with the recovery of the coupling 
between the molecular clocks in SCN and hippocampus. Of particular interest is the analysis 
of the molecular clock function in skin fibroblasts that exhibits alterations similar to the ones 
observed in the central nervous system: they occur before the onset of depression-like 
behavior, and are reversed by DMI treatment. Altogether, our results support and strengthen 
the evidence that the prenatal environment plays a critical role in the onset of 
neurodevelopmental disorders and that epigenetic mechanisms may be involved. 
MDD has been recognized by the World Health Organization as a major cause of disability. 
Worldwide, the prevalence is estimated to about 10% in the general population. The most 
commonly prescribed antidepressants, such as SSRI, take several months to show beneficial 
effects, and symptom remission is achieved in only 30-40% of MDD patients. In addition, the 
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identification of the effective therapy by trial-and-error is a very long process, during which 
the patients may lose hope and run a significantly increased risk of suicide attempts. 
Therefore, the identification of drugs that are likely to be effective before starting the 
treatment is critically important to reduce the burden on both the individual and society. Our 
findings suggest that alterations in circadian entrainment provide potential biomarkers for 
identifying subjects at risk of developing depression or depression relapse, as well as to 
predict the response to antidepressant treatment.  
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